JERICHO SCIENCES
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2020)
What this means for you
This application is over — abandoned 23 Mar 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87791549
- Mark type
- Design + words
- Filed
- 09 Feb 2018
- Published for opposition
- 26 Jun 2018
- Abandoned
- 23 Mar 2020
- Attorney of record
- Shane Cortesi
Goods and services
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals; Antivirals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Ocular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer; Syringes sold filled with pharmaceuticals for treating infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Owner
- Jericho Sciences, LLC, Nashville, TN, US
- Jericho Sciences, LLC, Nashville, TN, US
Prosecution history
- 23 Mar 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Aug 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2019 — SOU EXTENSION 2 GRANTED
- 19 Aug 2019 — SOU EXTENSION 2 FILED
- 19 Aug 2019 — SOU TEAS EXTENSION RECEIVED
- 09 Feb 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2019 — SOU EXTENSION 1 GRANTED
- 07 Feb 2019 — SOU EXTENSION 1 FILED
- 07 Feb 2019 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Jun 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jun 2018 — PUBLISHED FOR OPPOSITION
- 06 Jun 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 May 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER